Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C. (Q39695580)

14 September 2017

Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C. (English)

1 reference

14 September 2017

0 references

hepatocellular carcinoma

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Soo Aleman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

3

Ola Weiland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Ali Nangarhari

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

9 June 2016

1 reference

Clinical Infectious Diseases

14 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

723-729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Non-invasive evaluation of liver fibrosis using transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

External review and validation of the Swedish national inpatient register

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW362

21 January 2018

Identifiers

DOI

10.1093/CID/CIW362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27282709%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference